Results 161 to 170 of about 405,066 (236)

An Approach to Antibody‐Mediated Rejection in Pediatric Liver Transplantation

Pediatric Transplantation, Volume 30, Issue 9, September 2026.
ABSTRACT Antibody‐mediated rejection (AMR) is an important but infrequent cause of pediatric liver allograft injury. There is a lack of standardized guidance, and treatment approaches vary across institutions. A writing group from the Society of Pediatric Liver Transplantation conducted a comprehensive review of the published literature and collected ...
Catalina Jaramillo, Parmjeet Randhawa, Amrita Narang, Alison J. Gareau, Jody Weckwerth, Alisha Mavis, George Mazariegos, Katryn Furuya, Nanda Kerkar   +8 more
wiley   +1 more source

Blood Transcriptome Analysis of Septic Patients Reveals a Long Non-Coding Alu-RNA in the Complement C5a Receptor 1 Gene. [PDF]

Noncoding RNA, 2022
Emblem Å, Knutsen E, Jørgensen TE, Fure H, Johansen SD, Brekke OL, Mollnes TE, Karlsen BO.   +7 more
europepmc   +1 more source

Artificial Intelligence in Xenotransplantation: A Prioritized Roadmap for Early Clinical Translation, Opportunities and Challenges

Xenotransplantation, Volume 33, Issue 5, September/October 2026.
ABSTRACT Xenotransplantation represents a potential solution to the persistent global organ shortage, yet its clinical application remains stalled by complex immunologic responses, coagulation dysregulation, species‐specific biology, and infectious risks.
Kasra Shirini, Zoe Hahn, Joseph M. Ladowski, Alexander Schulick, Saghar Babadi, Alexandre Loupy, Kazuhiko Yamada, Raphael P. H. Meier   +7 more
wiley   +1 more source

Author Correction: Submolecular probing of the complement C5a receptor-ligand binding reveals a cooperative two-site binding mechanism. [PDF]

Commun Biol, 2021
Dumitru AC, Deepak RNVK, Liu H, Koehler M, Zhang C, Fan H, Alsteens D.   +6 more
europepmc   +1 more source

A Multicenter, Open‐Label, Phase 2 Trial Comparing Crizanlizumab Combined With Standard Therapy to Standard Therapy Alone on Renal Function in Patients With Sickle Cell Nephropathy (STEADFAST)

American Journal of Hematology, Volume 101, Issue 10, Page 2666-2671, October 2026.
Kenneth I. Ataga, Pablo Bartolucci, Santosh L. Saraf, Vimal K. Derebail, Adlette Inati, Jeffrey D. Lebensburger, Laurie DeBonnett, Rodolfo D. Cancado, Claire C. Sharpe   +8 more
wiley   +1 more source

Complement C5a-triggered differentiated HL-60 stimulates migration of THP-1 monocytic leukocytes via secretion of CCL2. [PDF]

FEBS Open Bio, 2021
Dewan SMR, Osaka M, Deushi M, Yoshida M.
europepmc   +1 more source

Complement C5a Promotes Epithelial-Mesenchymal Transition in Pterygium via C5aR Activation. [PDF]

Invest Ophthalmol Vis Sci
Han J, Gong Q, Wang H, Xie B, Ye L, Shen L, Hu L.   +6 more
europepmc   +1 more source

Macrophages self-generate and refine chemotactic gradients during migration towards complement C5a. [PDF]

PLoS Biol
Kiran A, Thomason PA, Versluis DM, Paschke PI, Donnelly H, Tweedy L, Lilla S, Bravo-Ferrer I, Shergold A, Devlin R, Roberts EW, Insall RH.   +11 more
europepmc   +1 more source

Complement C5a receptor 1 antagonist attenuates alveolar hypoplasia induced by pulmonary hypoperfusion and its underlying mechanisms. [PDF]

Front Immunol
Liu C, Zheng S, Wang Y, Wang Z, Li D, Li H, Xue Y, Wang Z, She S, Ye L, Ruan P, Fu L, Sun Q.   +12 more
europepmc   +1 more source

Inhibition of complement C5a receptor protects lung cells and tissues against lipopolysaccharide-induced injury via blocking pyroptosis. [PDF]

Aging (Albany NY), 2021
Wang R, Wang Y, Hu L, Lu Z, Wang X.
europepmc   +1 more source